Search for an orphan drug
Other search option(s)
47 Result(s)
Substance(s)
- 3-(5-amino-2-methyl-4-oxoquinazolin-3(4H)-yl)piperidine-2,6-dione hydrochloride
- 5-(4,6-dimorpholino-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine
- Allogeneic multi-virus specific T lymphocytes targeting BK virus, cytomegalovirus, human herpesvirus-6, Epstein Barr virus and adenovirus
- Autologous CD4+ and CD8+ T cells expressing a CD19-specific chimeric antigen receptor
- Autologous engineered anti -CD19 Chimeric Antigen Receptor (CAR +) T -cells
- Axicabtagene ciloleucel
- Brentuximab vedotin
- Enzastaurin hydrochloride
- Everolimus
- Humanised Fc engineered monoclonal antibody against CD19
- Humanised anti-CD37 monoclonal antibody conjugated to maytansinoid DM1
- Ibrutinib
- Iodine (131I) tositumomab
- Lenalidomide
- Mocetinostat
- Obinutuzumab
- Pixantrone dimaleate
- Polatuzumab vedotin
- Pralatrexate
- Recombinant histidine-tagged idiotype immunoglobulin Fab fragment of clonal B-cell receptors
- Rituximab
- Selinexor
- Tazemetostat
- Valproic acid, sodium
- Venetoclax
- haematopoietic stem cells and blood progenitors umbilical cord-derived expanded with (1R, 4R)-N1-(2-benzyl-7-(2-methyl-2H-tetrazol-5-yl)-9H-pyrimido[4,5-b]indol-4-yl)cyclohexane-1,4-diamine dihydrobromide dihydrate